1) Advanced nonseminomatous germ cell tumors
晚期睾丸癌
3) adenocarcinoma of testis
睾丸腺癌
4) Cancer-testis antigen
癌-睾丸抗原
1.
Prediction of HLA-A2/A3-restricted broad spectrum CTL epitope derived from the cancer-testis antigen SSX-3;
癌-睾丸抗原SSX-3的HLA-A2/A3限制性CTL广谱表位的预测
2.
Objective: To investigate the expression of Cancer-Testis Antigen SCP-1 mRNA in human nasopharyngeal carcinoma, and explore the potential possibility in the immunodiagnosis and immunotherapy of nasopharyngeal carcinoma with SCP-1.
目的:了解癌-睾丸抗原SCP-1 mRNA在人鼻咽癌的表达情况,探讨SCP-1用于鼻咽癌免疫诊疗的可行性。
5) Cancer/testis antigen
癌/睾丸抗原
1.
Cancer/testis antigen(CTA) genes are specifically expressed in the normal testis and various types of cancer cells,while not or expressed with very low level in other normal tissues.
癌/睾丸抗原(Cancer/Testis Antigen,CTA)基因在正常睾丸组织的生殖细胞和多种不同组织类型的癌细胞中特异表达,在其它正常组织不表达或表达水平较低,并且在癌症患者中有抗原性免疫反应,认为是一类理想的肿瘤疫苗靶分子。
6) Testicular carcinoma-in-situ
睾丸原位癌
补充资料：睾丸绒毛膜上皮癌
睾丸绒毛膜上皮癌
chorioepithelioma of testis
占生殖细胞瘤的1%，瘤体小，恶性度高，生长快，早期有血行转移。含有合体滋养细胞和细胞滋养层细胞两种细胞成分。常与胚胎癌、畸胎瘤和精原细胞瘤混合存在。预后较差。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条